condition	mean	min	max
0.1 mm CuSO4,WT	0.0	0.0	0.0
1-napp-1,WT	0.0	0.0	0.0
1n,MATa,NaCl,WT	0.0	0.0	0.0
1n,MATa,WT	0.0	0.0	0.0
1n,MATa,unstressed,WT	0.0	0.0	0.0
1n,MATalpha,WT	0.0	0.0	0.0
1n,WT	0.0	0.0	0.0
1n,addition of 1nm-pp1,WT	28.3326	0.0	56.6652
200 mm hu,WT	0.0	0.0	0.0
39C,YPD,WT	0.0	0.0	0.0
SC-URA + 20g/l glucose,WT	0.0	0.0	0.0
SDC,WT	0.0	0.0	0.0
WT	0.9309309803921568	0.0	179.083
YEP + lactic acid + 2% gal,WT	0.0	0.0	0.0
YEP + lactic acid,WT	0.0	0.0	0.0
YP + 3% glycerol,WT	0.0	0.0	0.0
YPD,WT	0.0	0.0	0.0
YPDA,WT	0.0	0.0	0.0
YPEG,WT	0.0	0.0	0.0
azetidine,YPD,WT	0.0	0.0	0.0
cmk treatment,WT	0.0	0.0	0.0
dmso,WT	0.0	0.0	0.0
elutriation + 1nm-pp1,WT	0.0	0.0	0.0
fluco,YPD,WT	0.0	0.0	0.0
gal, 2h + hu 200 mm,WT	0.0	0.0	0.0
gal, 4h + hu 200 mm,WT	0.0	0.0	0.0
gal,WT	0.0	0.0	0.0
glucose,WT	0.0	0.0	0.0
heatshock,WT	65.08278333333334	0.0	177.82
hu, 1h,WT	0.0	0.0	0.0
hu, 2h,WT	0.0	0.0	0.0
hu, 4h,WT	0.0	0.0	0.0
log,WT	10.333652173913043	0.0	80.0607
med 35 6aa,WT	0.0	0.0	0.0
med 35 ammonium,WT	0.0	0.0	0.0
med 35 complete,WT	0.0	0.0	0.0
menadione,YPD,WT	0.0	0.0	0.0
mid-log,WT	13.506333333333332	0.0	40.519
mid-log,untreated,WT	0.0	0.0	0.0
mid-log,vts1 OE,WT	0.0	0.0	0.0
min med, chemostat,WT	0.0	0.0	0.0
rap,YPD,WT	0.0	0.0	0.0
ribo depletion,WT	0.0	0.0	0.0
salt,YPD,WT	0.0	0.0	0.0
stat,WT	0.0	0.0	0.0
syn dext,WT	0.0	0.0	0.0
synthetic complete med,20C,WT	0.0	0.0	0.0
synthetic defined med,WT	0.0	0.0	0.0
treated,WT	0.0	0.0	0.0
tunicamycin,YPD,WT	0.0	0.0	0.0
untreated,WT	16.952535714285716	0.0	113.212
ypsorbitol (2.02%),YPD,WT	0.0	0.0	0.0